Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Macrocyclic compounds as HCV entry inhibitors

A technology of compounds and inhibitors, applied in the field of new compounds of formula I, can solve the problem that the degree of correlation between viruses and cellular factors is not fully understood, etc.

Inactive Publication Date: 2015-10-21
BRISTOL MYERS SQUIBB CO
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The extent to which disease progression is related to viral and cellular factors is not fully understood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Macrocyclic compounds as HCV entry inhibitors
  • Macrocyclic compounds as HCV entry inhibitors
  • Macrocyclic compounds as HCV entry inhibitors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0034] Unless expressly stated otherwise elsewhere in this application, the following terms have the following meanings. "H" means hydrogen, including isotopes thereof, such as deuterium. "Halogen" means fluorine, chlorine, bromine or iodine. "Alkyl" means a straight or branched chain alkyl group consisting of 1-6 carbons. "Alkenyl" means a straight or branched chain alkyl group consisting of 2 to 6 carbons having at least one double bond. "Cycloalkyl" means a single ring system consisting of 3-8 carbons. "Alkylene" means a straight or branched chain divalent alkyl group. "Alkenylene" means a straight or branched divalent alkyl group having at least one double bond. "Cycloalkylene" means a divalent cycloalkane moiety consisting of 3 to 7 carbons and includes gem-divalencies (eg, 1,1-cyclopropanediyl) as well as non-gem-divalencies (eg, 1 ,4-cyclohexanediyl). "Alkylidinyl" means a divalent alkene substituent in which the divalence occurs on the same carbon of the alkene. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Patent Application 61 / 761,868, filed February 7, 2013, which is hereby incorporated by reference. technical field [0003] The present invention relates to novel compounds of formula I, including pharmaceutically acceptable salts thereof, which have anti-hepatitis C virus (HCV) activity and are useful for treating HCV-infected patients. The invention also relates to compositions and methods of using these compounds. Background technique [0004] An estimated 170 million people worldwide are chronically infected with hepatitis C virus (HCV), with 3 to 4 million infected in the United States alone (Boyer, N. and Marcellin, P.J. Hepatology. 2000, 32:98-112; Alter, M.J. et al. Engl. J. Med. 1999, 341:556-562). Before the mid-1990s, blood transfusion with infected blood products was the main route of HCV infection. After the introduction of blood screening methods, infec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D498/08C07D498/18C07D498/22A61K31/53A61P31/12
CPCC07D498/08C07D498/18C07D498/22A61K31/53A61K31/551C07D498/20A61P1/16A61P31/12A61P31/14A61P43/00A61K45/06
Inventor 汪涛张钟兴尹志伟孙力强E·麦尔赵倩P·M·斯科拉
Owner BRISTOL MYERS SQUIBB CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products